Medication info
Orphenesemi Controlled-release Tablet

Orphenesemi Controlled-release Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
Pale yellow round controlled-release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202002826 · Approved 2020.04.21

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: Adjust the dose according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended; thereafter, allow an interval of at least 12 hours between doses, and do not exceed 8 tablets per day. Do not administer this product for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this product should be continued. Nausea, vomiting, pruritus, constipation, dizziness, drowsiness, and other symptoms may occur during administration of this product; closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to adults aged 75 years or older, administer this product at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this product in patients with renal impairment have not been established; therefore, administration is not recommended. Patients with hepatic impairment: The safety and efficacy of this product in patients with hepatic impairment have not been established; therefore, administration is not recommended.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain of moderate to severe intensity
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: Adjust the dose according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended; thereafter, allow an interval of at least 12 hours between doses, and do not exceed 8 tablets per day. Do not administer this product for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this product should be continued. Nausea, vomiting, pruritus, constipation, dizziness, drowsiness, and other symptoms may occur during administration of this product; closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to adults aged 75 years or older, administer this product at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this product in patients with renal impairment have not been established; therefore, administration is not recommended. Patients with hepatic impairment: The safety and efficacy of this product in patients with hepatic impairment have not been established; therefore, administration is not recommended.

Precautions

This medication may burden the liver, so individuals who usually consume alcohol daily should consult a physician or pharmacist before taking it. If severe rashes, blisters, or red spots appear on the skin during treatment, discontinue use immediately and inform healthcare personnel. The ingredients in this medication can cause seizures, so patients with a history of seizures or at high risk of seizures should use it cautiously. Additionally, taking this medication with certain antidepressants or other pain relievers, narcotic drugs may increase the risk of seizures, so it is essential to consult a professional. Patients with asthma who have weak respiratory function are at risk of severe respiratory suppression when taking this medication, so it should be administered in a facility equipped with medical equipment. Using this medication with alcohol or sedatives, which also depress the central nervous system, can lead to severe drowsiness, respiratory suppression, or even coma; caution is necessary. Patients with head injuries or brain diseases should use this medication carefully as it may increase intracranial pressure. This medication has the potential for dependence; thus, dosages and duration should be adjusted according to a physician's instructions when used for a long time. Especially, patients with weak liver function are at risk of liver damage, so they must consult healthcare personnel before taking this medication. Children, especially those under 12 years old or adolescents under 18 years old who have undergone tonsillectomy, should not use this medication. Pregnant or breastfeeding women should consult a physician before taking this medication, as it may pose risks to the fetus or newborn. Caution is advised when driving or operating machinery, as drowsiness or dizziness may occur. In cases of overdose, severe respiratory suppression or liver damage may occur, so immediate emergency treatment is required if symptoms appear. During the use of this medication, care must be taken to avoid taking other pain relievers or medications containing acetaminophen concurrently.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, fainting, withdrawal symptoms, hypertension, hypertension exacerbation, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, migraine exacerbation, involuntary muscle contractions, sensory disturbances, confusion, dizziness, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, confusion, euphoria, insomnia, neurosensitivity, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thinking, anemia, respiratory distress, proteinuria, urination disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vascular relaxation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, changes in appetite, exercise intolerance, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, serotonin syndrome, asthma exacerbation, withdrawal symptoms, delirium, miosis, mydriasis, speech disorder, movement disorder, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, allergic reaction, thrombocytopenia, agranulocytosis, hypoprothrombinemia, propylene glycol acidosis, leukoplakia, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscular weakness, myalgia, blurred vision, conjunctivitis, reduced immune response, sensory abnormalities, lethargy, taste disturbances, involuntary muscle contractions, peripheral edema, pallor, blood pressure fluctuations, cough, runny nose, urinary red cells positive, blood pressure elevation, palpitations, menstrual irregularities, breast cancer, injury, fever, chest discomfort, facial swelling, hyperhidrosis, cold sweat, urination disorders, hematuria, dark urine, anuria, urinary retention, urinary incontinence, dry mouth, abdominal pain, abdominal discomfort, abdominal distension, upper abdominal discomfort, upper abdominal pain, peptic ulcer, belching, weakness, drowsiness, insomnia, decreased appetite, anxiety, depression, neurosensitivity, emotional instability, hallucinations, depersonalization, anemia, reduced hemoglobin, reduced red blood cells, reduced white blood cells, increased white blood cells, thrombocytopenia, palpitations, aortic stenosis, bleeding, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, cholecystitis, paralytic ileus, hiccups, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, drowsiness, insomnia, decreased appetite, anxiety, depression, neurosensitivity, emotional instability, hallucinations, depersonalization, anemia, reduced hemoglobin, reduced red blood cells, reduced white blood cells, increased white blood cells, thrombocytopenia, palpitations, hypertension, arrhythmia, tachycardia, hypertension exacerbation, aortic stenosis, bleeding, elevated cholesterol, weight loss, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, cholecystitis, paralytic ileus, confusion, nausea, dizziness, respiratory distress, migraine, speech disorder, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose, heartburn, unspecified gastrointestinal disorder, acute gastritis, cold, upper respiratory infection, systemic weakness, motion sickness, transient ischemic attack, back pain, lethargy, memory impairment, ineffective treatment, facial flushing, back pain, headache, transient ischemic attack, heartburn, unspecified gastrointestinal disorder, acute gastritis, systemic weakness, weakness, lethargy, bleeding, hiccups, paralytic ileus, abnormalities in kidney function tests, increased salivation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is best to store the medication at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pale yellow round controlled-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.